Ankita S. Durge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ankita S. Durge has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Rashmi Santosh Tupe
Symbiosis School of Biological Sciences (SSBS), Symbiosis International (Deemed University) (SIU), Pune, India
2 shared publications Ashwini D. Jagdale
1 shared publicationChaitra R. Bandiwadekar
1 shared publication- Isha Sharma
Department of Pathology, Northwestern University, Chicago, IL 60611, USA
1 shared publication Tejaswini A. Pachpor
1 shared publication
Latest Publications
- 25 July 2023
- Published by Elsevier in Food Hydrocolloids
- Vol. 145
Evaluation of different sugars for glycation modifications of chitosan to improve its functionality for food preservation
- 25 July 2023
- Published by Elsevier in Food Hydrocolloids
- Vol. 145
Evaluation of different sugars for glycation modifications of chitosan to improve its functionality for food preservation
- Open Access
- 19 October 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (10) , 2623
Glycation-Associated Diabetic Nephropathy and the Role of Long Noncoding RNAs
The glycation of various biomolecules is the root cause of many pathological conditions associated with diabetic nephropathy and end-stage kidney disease. Glycation imbalances metabolism and increases renal cell injury. Numerous therapeutic measures have narrowed down the adverse effects of endogenous glycation, but efficient and potent measures are miles away. Recent advances in the identification and characterization of noncoding RNAs, especially the long noncoding RNAs (lncRNAs), have opened a mammon of new biology to explore the mitigations for glycation-associated diabetic nephropathy. Furthermore, tissue-specific distribution and condition-specific expression make lncRNA a promising key for second-generation therapeutic interventions. Though the techniques to identify and exemplify noncoding RNAs are rapidly evolving, the lncRNA study encounters multiple methodological constraints. This review will discuss lncRNAs and their possible involvement in glycation and advanced glycation end products (AGEs) signaling pathways. We further highlight the possible approaches for lncRNA-based therapeutics and their working mechanism for perturbing glycation and conclude our review with lncRNAs biology-related future opportunities.
- 19 October 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (10) , 2623
Open AccessGlycation-Associated Diabetic Nephropathy and the Role of Long Noncoding RNAs
The glycation of various biomolecules is the root cause of many pathological conditions associated with diabetic nephropathy and end-stage kidney disease. Glycation imbalances metabolism and increases renal cell injury. Numerous therapeutic measures have narrowed down the adverse effects of endogenous glycation, but efficient and potent measures are miles away. Recent advances in the identification and characterization of noncoding RNAs, especially the long noncoding RNAs (lncRNAs), have opened a mammon of new biology to explore the mitigations for glycation-associated diabetic nephropathy. Furthermore, tissue-specific distribution and condition-specific expression make lncRNA a promising key for second-generation therapeutic interventions. Though the techniques to identify and exemplify noncoding RNAs are rapidly evolving, the lncRNA study encounters multiple methodological constraints. This review will discuss lncRNAs and their possible involvement in glycation and advanced glycation end products (AGEs) signaling pathways. We further highlight the possible approaches for lncRNA-based therapeutics and their working mechanism for perturbing glycation and conclude our review with lncRNAs biology-related future opportunities.